BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 22674352)

  • 1. Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms.
    Lee AH; Weintraub D
    Mov Disord; 2012 Jun; 27(7):858-63. PubMed ID: 22674352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis.
    Kulick CV; Montgomery KM; Nirenberg MJ
    Parkinsonism Relat Disord; 2018 Sep; 54():40-45. PubMed ID: 29653909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia.
    Barrett MJ; Smolkin ME; Flanigan JL; Shah BB; Harrison MB; Sperling SA
    Parkinsonism Relat Disord; 2017 Oct; 43():56-60. PubMed ID: 28735797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.
    Ffytche DH; Pereira JB; Ballard C; Chaudhuri KR; Weintraub D; Aarsland D
    J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):325-331. PubMed ID: 28315846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of psychotic symptoms in a community-based Parkinson disease sample.
    Mack J; Rabins P; Anderson K; Goldstein S; Grill S; Hirsch ES; Lehmann S; Little JT; Margolis RL; Palanci J; Pontone G; Weiss H; Williams JR; Marsh L
    Am J Geriatr Psychiatry; 2012 Feb; 20(2):123-32. PubMed ID: 21617521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric comorbidities in patients with Parkinson disease and psychosis.
    Marsh L; Williams JR; Rocco M; Grill S; Munro C; Dawson TM
    Neurology; 2004 Jul; 63(2):293-300. PubMed ID: 15277623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deconstructing psychosis and misperception symptoms in Parkinson's disease.
    Nishio Y; Yokoi K; Uchiyama M; Mamiya Y; Watanabe H; Gang M; Baba T; Takeda A; Hirayama K; Mori E
    J Neurol Neurosurg Psychiatry; 2017 Sep; 88(9):722-729. PubMed ID: 28600444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.
    Williams-Gray CH; Foltynie T; Lewis SJ; Barker RA
    CNS Drugs; 2006; 20(6):477-505. PubMed ID: 16734499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study.
    Aarsland D; Larsen JP; Cummins JL; Laake K
    Arch Neurol; 1999 May; 56(5):595-601. PubMed ID: 10328255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive correlates of psychosis in patients with Parkinson's disease.
    Moustafa AA; Krishna R; Frank MJ; Eissa AM; Hewedi DH
    Cogn Neuropsychiatry; 2014; 19(5):381-98. PubMed ID: 24446773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson's Disease.
    Pachi I; Papadopoulos V; Koros C; Simitsi AM; Bougea A; Bozi M; Papagiannakis N; Soldatos RF; Kolovou D; Pantes G; Scarmeas N; Paraskevas G; Voumvourakis K; Papageorgiou SG; Kollias K; Stefanis N; Stefanis L
    J Parkinsons Dis; 2023; 13(7):1185-1197. PubMed ID: 37840503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms.
    Fénelon G
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):18-25. PubMed ID: 18323763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosis in Parkinson's Disease: Looking Beyond Dopaminergic Treatments.
    Rojas M; Chávez-Castillo M; Duran P; Ortega Á; Bautista-Sandoval MJ; Salazar J; Riaño-Garzón M; Chacín M; Medina-Ortiz O; Palmar J; Cudris-Torres L; Bermúdez V
    Curr Pharm Des; 2022; 28(33):2725-2741. PubMed ID: 36321314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual symptoms in Parkinson's disease and Parkinson's disease dementia.
    Archibald NK; Clarke MP; Mosimann UP; Burn DJ
    Mov Disord; 2011 Nov; 26(13):2387-95. PubMed ID: 21953737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of Cannabis on hallucinations in Parkinson's disease patients.
    Cravanas B; Frei K
    J Neurol Sci; 2020 Dec; 419():117206. PubMed ID: 33161300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hallucinations and psychosis in Parkinson's disease.
    Rabey JM
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S105-10. PubMed ID: 20123547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric issues in cognitive impairment.
    Aarsland D; Taylor JP; Weintraub D
    Mov Disord; 2014 Apr; 29(5):651-62. PubMed ID: 24757113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and Characteristics of Psychosis in Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Chendo I; Silva C; Duarte GS; Prada L; Voon V; Ferreira JJ
    J Parkinsons Dis; 2022; 12(1):85-94. PubMed ID: 34806620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.